Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now official registry

End of Life clinical trials

Every US clinical trial registered for End of Life — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

11 US clinical trials · 4 currently recruiting

The research picture

End of Life has 11 registered US clinical trials, 4 of them open to new participants right now — about 36% of the total.

4
recruiting participants now
36%
of trials open to enrollment
0
in Phase 3–4 (later-stage)
2
top sponsor: Stanford University

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING NA 2,996 participants

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Stanford University

NCT05297734

RECRUITING NA 2,600 participants

Embedded Palliative Care in the MICU

Washington University School of Medicine

NCT06574672

RECRUITING NA 792 participants

Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)

University of South Florida

NCT06722352

RECRUITING 15 participants

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

UNC Lineberger Comprehensive Cancer Center

NCT05440929

ACTIVE NOT RECRUITING NA 900 participants

Wishes to Improve Support and Humanity at End-of-life in Safety-net Hospitals

University of California, Los Angeles

NCT06277310

ACTIVE NOT RECRUITING NA 184 participants

Feasibility of the Comfort Measures Only Time Out (CMOT)

Beth Israel Deaconess Medical Center

NCT05861323

ACTIVE NOT RECRUITING NA 60 participants

Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication

Dana-Farber Cancer Institute

NCT07147023

ACTIVE NOT RECRUITING NA 15 participants

Study of Poetic Dignity Therapy for Sexual and Gender Minority Patients With Cancer

Memorial Sloan Kettering Cancer Center

NCT06293456

COMPLETED NA 160 participants

Lay Health Worker Engage, Educate, and Encourage Patients to Share

Stanford University

NCT03699748

COMPLETED NA 65 participants

Conducting Perioperative Code Status and Goals of Care Discussions: A Bi-Institutional Study to Develop a Novel, Evidence-Based Curriculum for Anesthesiology Trainees

Brigham and Women's Hospital

NCT04045886

COMPLETED NA 9 participants

Virtual Reality at End-of-life

State University of New York at Buffalo

NCT06149429

Reading the End of Life Trial Landscape

ClinicalTrials.gov lists 11 US studies indexed under End of Life, and 4 of those are currently open to recruitment — roughly 36% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for End of Life shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 0 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for End of Life is led by Stanford University with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 11 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for End of Life?

PlainTrial tracks 11 US clinical trials for End of Life, of which 4 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for End of Life?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →